Assessment of myocardial viability using 123I-labeled iodophenylpentadecanoic acid at sustained low flow or after acute infarction and reperfusion

Journal of Nuclear Medicine

Volumn 40, Issue 5, 1999, Pages 821-828

  Yang, Joo Y ^a   Ruiz, Mirta ^a   Calnon, Dennis A ^a   Watson, Denny D ^a   Beller, George A ^a   Glover, David K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

201Tl; Fatty acids; Myocardial infarction; Myocardial ischemia; Myocardial viability; Radionuclide imaging

Indexed keywords

15 (2 IODOPHENYL)PENTADECANOIC ACID I 123; FATTY ACID; IODINE 125; TRACER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DIAGNOSTIC VALUE; DOG; FATTY ACID SYNTHESIS; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART SCINTISCANNING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

ANIMALS; DOGS; HEART; IODINE RADIOISOTOPES; IODOBENZENES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; THALLIUM RADIOISOTOPES; TIME FACTORS;

EID: 0032899194     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 11C-palmitate. Circulation. 1977;55:853-857.
2. 11C-palmitate. Circulation. 1980;61:242-254.
3. Machulla HJ, Marsmann M, Dutschka K. Biochemical concept and synthesis of a radioiodinated phenyl fatty acid for in vivo metabolic studies of the myocardium. Eur J Nucl Med. 1980;5:171-173.
4. Reske SN, Machulla HJ, Winkler C. Metabolism of 15-p-(I-123-phenyl)-pentadecanoic acid in hearts of rats. J Nucl Med. 1982;23:10-18.
5. 14C) palmitic acid in murine tissues. J Nucl Med. 1984;25:1335-1342.
6. Iskandrian AS, Powers J, Cave V, Wasserleben V, Cassell D, Heo J. Assessment of myocardial viability by dynamic tomographic 123 iodopenylpentadecanoic acid imaging: comparison with rest-redistribution thallium 201 imaging. J Nucl Cardiol. 1995;2:101-109.
7. Smith WH, Watson DD. Technical aspects of myocardial planar imaging with technetium-99m-sestamibi. Am J Cardiol. 1990;66:16E-22E.
8. Heymann MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977;20:55-79.
9. Visser FC, van Eenige MJ, Western G, et al. Metabolic fate of radioiodinated heptadecanoic acid in the normal canine heart. Circulation. 1985;72:565-571.
10. Schön HR, Schelbert HR, Robinson GD, et al. C-11-labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography I. Kinetics of C-11 palmitic acid in normal myocardium. Am Heart J. 1982;103:532-547.
11. 14C]palmitic acid in murine tissues. J Nucl Med. 1984;25:1335-1342.
12. Sansoy V, Glover DK, Watson DD, et al. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation. 1995;92:994-1004.
13. Koplan BA, Beller GA, Ruiz M, Yang JY, Watson DD, Glover DK. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction. J Nucl Med. 1996;37:1398-1402.
14. Relias JS, Corbett JR, Kulkarni P, et al. Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography. Am J Cardiol. 1983;52:1326-1332.
15. Schwaiger M, Schelbert HR, Ellison D, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol. 1985;6:335-347.
16. Fox KAA, Abendschein DR, Ambos HD, Sobel BE, Bergmann SR. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium: implications for quantifying myocardial metabolism tomographically. Circ Res. 1985;57: 232-243.
17. Corbett J. Clinical experience with iodine-123-iodophenylpentadecanoic acid. J Nucl Med. 1994;35(suppl):32S-37S.
18. Hansen CL. Preliminary report of an ongoing phase I/II dose range, safety, and efficacy study of iodine-123-phenylpentadecanoic acid for the identification of viable myocardium. J Nucl Med. 1994;35(suppl):38S-42S.
19. Hansen CL, Heo J, Iskandrian AS. Prediction of improvement of left ventricular function after coronary revascularization from alterations in myocardial metabolic activity detected with I-123-phenylpentadecanoic acid dynamic SPECT imaging [abstract]. J Am Coll Cardiol. 1994;23:344A.
20. Murray GL, Schad NC, Magill HL, Vander Zwaag R. Myocardial viability assessment with dynamic low-dose iodine-123-iodophenylpentadecanoic acid metabolic imaging: comparison with myocardial biopsy and reinjection SPECT thallium after myocardial infarction. J Nucl Med. 1994;35(suppl):43S-48S.
21. Powers J, Cave V, Wasserliben V, Cassel D, Heo J, Iskandrian AS. Mechanisms and implications of redistribution during dynamic rest SPECT I-123 IPPA imaging [abstract]. J Am Coll Cardiol. 1994;23:423A.
22. Tamaki N, Kawamoto M. The use of iodinated free fatty acids for assessing fatty acid metabolism. J Nucl Cardiol. 1994;1:S72-S78.
23. Hansen CL, Heo J, Oliner C, Van Decker W, Iskandrian AS. Prediction of improvement in left ventricular function with iodine-123-IPPA after coronary revascularization. J Nucl Med. 1995;36:1987-1993.
24. Willerson JT, Parkey RW, Maximilian BL, Bonte FJ. Technetium-99m stannous pyrophosphate "hot spot" imaging to detect acute myocardial infarcts. Cardiovasc Clin. 1979;13:139-148.